Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 580

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 580
---
 | ​                           | ​ |     ​ | ​ | ​ | ​ | % change |   |     |   | ​ | ​ | ​    | ​ |     ​ | ​ | ​ | ​ | % change |   |      |   | ​ |
| Other income, net | ​ | ​ | ​                           | $ | 3,586 | ​ | ​ | ​ | ​        | ​ | 74% | ​ | ​ | ​ | ​    | $ | 2,061 | ​ | ​ | ​ | ​        | ​ | 221% | ​ | ​ |

For the year ended December 31, 2023 compared to the year ended December 31, 2022, the increase in other income, net was primarily due to an increase in interest income resulting from a higher yield on our portfolio of investments during the year ended December 31, 2023 and an increase in accretion income from our available-for-sale marketable securities. We reviewed our available-for-sale debt securities as of December 31, 2023 and 2022 and determined that no credit loss expense was necessary as a result of unrealized losses on various securities not being considered material individually or in aggregate, and we expect that the cost basis of these available-for-sale securities is recoverable. We do not expect that unrealized losses on our available-for-sale debt securities will impact our liquidity in the short-term or long-term since our investments all mature at various dates through November 2024 based on capital requirements, and it is not more likely than not that we will be required to sell these investments before recovery of their amortized cost bases. Non-cash Interest Expense on Liability Related to the Sales of Future Royalties and Milestones

| ​                                                                                         
 ​                                                                                         | ​ 
 ​ | ​ 
 ​ | Year Ended December 31,     
 2023                        |   |      |   |   |   |          |   |     |   | ​ | ​ | 2022 |   |   |   |   |   |          |   |     |   | ​ 
 ​ |
|:------------------------------------------------------------------------------------------|:--|:--|:----------------------------|:--|-----:|:--|:--|:--|:---------|:--|:----|:--|:--|:--|:-----|:--|:--|:--|:--|:--|:---------|:--|:----|:--|:--|